| Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease WM Crist, JR Anderson, JL Meza, C Fryer, RB Raney, FB Ruymann, ... Journal of Clinical Oncology 19 (12), 3091-3102, 2001 | 1281 | 2001 |
| Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group JL Meza, J Anderson, AS Pappo, WH Meyer Journal of clinical oncology 24 (24), 3844-3851, 2006 | 408 | 2006 |
| Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group S Bhatia, W Landier, M Shangguan, L Hageman, AN Schaible, AR Carter, ... Journal of Clinical Oncology 30 (17), 2094-2101, 2012 | 372 | 2012 |
| CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson’s disease JAH Saunders, KA Estes, LM Kosloski, HE Allen, KM Dempsey, ... Journal of Neuroimmune Pharmacology 7, 927-938, 2012 | 359 | 2012 |
| Translating the Pittsburgh sleep quality index into Arabic KH Suleiman, BC Yates, AM Berger, B Pozehl, J Meza Western journal of nursing research 32 (2), 250-268, 2010 | 341 | 2010 |
| Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis AP Singh, N Moniaux, SC Chauhan, JL Meza, SK Batra Cancer research 64 (2), 622-630, 2004 | 313 | 2004 |
| Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer EG Rogan, AF Badawi, PD Devanesan, JL Meza, JA Edney, WW West, ... Carcinogenesis 24 (4), 697-702, 2003 | 267 | 2003 |
| Randomized clinical trial of therapeutic music video intervention for resilience outcomes in adolescents/young adults undergoing hematopoietic stem cell transplant: a report … SL Robb, DS Burns, KA Stegenga, PR Haut, PO Monahan, J Meza, ... Cancer 120 (6), 909-917, 2014 | 243 | 2014 |
| Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG SS Donaldson, J Meza, JC Breneman, WM Crist, F Laurie, SJ Qualman, ... International Journal of Radiation Oncology* Biology* Physics 51 (3), 718-728, 2001 | 240 | 2001 |
| MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins P Chaturvedi, AP Singh, N Moniaux, S Senapati, S Chakraborty, JL Meza, ... Molecular cancer research 5 (4), 309-320, 2007 | 232 | 2007 |
| Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly … R Beverly Raney, DO Walterhouse, JL Meza, RJ Andrassy, JC Breneman, ... Journal of Clinical Oncology 29 (10), 1312-1318, 2011 | 229 | 2011 |
| Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene D Chakravarti, PC Mailander, KM Li, S Higginbotham, HL Zhang, ... Oncogene 20 (55), 7945-7953, 2001 | 226 | 2001 |
| MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells P Chaturvedi, AP Singh, S Chakraborty, SC Chauhan, S Bafna, JL Meza, ... Cancer research 68 (7), 2065-2070, 2008 | 200 | 2008 |
| Neuromagnetic evidence of abnormal movement-related beta desynchronization in Parkinson's disease E Heinrichs-Graham, TW Wilson, PM Santamaria, SK Heithoff, ... Cerebral cortex 24 (10), 2669-2678, 2014 | 185 | 2014 |
| Availability and use of palliative care and end-of-life services for pediatric oncology patients DL Johnston, K Nagel, DL Friedman, JL Meza, CA Hurwitz, S Friebert Journal of Clinical Oncology 26 (28), 4646-4650, 2008 | 170 | 2008 |
| Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line KG Kohlgraf, AJ Gawron, M Higashi, JL Meza, MD Burdick, S Kitajima, ... Cancer research 63 (16), 5011-5020, 2003 | 169 | 2003 |
| Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk … DO Walterhouse, AS Pappo, JL Meza, JC Breneman, AA Hayes-Jordan, ... Journal of Clinical Oncology 32 (31), 3547-3552, 2014 | 154 | 2014 |
| The molecular etiology of breast cancer: evidence from biomarkers of risk NW Gaikwad, L Yang, P Muti, JL Meza, S Pruthi, JN Ingle, EG Rogan, ... International journal of cancer 122 (9), 1949-1957, 2008 | 152 | 2008 |
| Weight patterns in children with higher risk ALL: a report from the Children's Oncology Group (COG) for CCG 1961 JS Withycombe, JE Post‐White, JL Meza, RG Hawks, LM Smith, N Sacks, ... Pediatric blood & cancer 53 (7), 1249-1254, 2009 | 148 | 2009 |
| Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial HE Gendelman, Y Zhang, P Santamaria, KE Olson, CR Schutt, D Bhatti, ... NPJ Parkinson's disease 3 (1), 10, 2017 | 144 | 2017 |
